Consolidated statement of financial position

In thousands of euro (before profit appropriation) Note 31 December 2018 31 December 2017
Assets
Property, plant and equipment 17 261,555 205,904
Intangible assets and goodwill 18 168,023 96,229
Investment property 19 643 830
Trade and other receivables 21 13,690 9,298
Equity-accounted investees 20 25,392 24,018
Deferred tax assets 16 2,099 2,998
Non-current assets   471,402 339,277
 
Inventories 22 93,555 72,010
Biological assets 23 4,314 4,714
Trade and other receivables 21 250,618 208,170
Current tax assets 16 2,072 86
Cash and cash equivalents 24 51,756 161,297
Assets held for sale 25 - 1,737
Current assets   402,315 448,014
 
Total assets   873,717 787,291
 
Equity
Share capital   1,063 1,063
Share premium   143,554 143,554
Treasury share reserve   -61 -55
Translation reserve   -6,653 -5,692
Hedging reserve   -896 -
Other reserves and retained earnings   239,990 207,878
Unappropriated result   58,590 58,554
Equity attributable to shareholders of the Company 26 435,587 405,302
Non-controlling interests 34 5,166 4,629
 
Total equity   440,753 409,931
 
Liabilities
Loans and borrowings 29 52,540 44,508
Employee benefits 15 33,496 46,910
Provisions 30 2,024 2,249
Trade and other payables 31 41,258 8,255
Deferred tax liabilities 16 13,174 9,939
Non-current liabilities   142,492 111,861
 
Bank overdrafts 24 13,307 49,690
Loans and borrowings 29 2,963 28
Provisions 30 1,372 1,132
Trade and other payables 31 267,695 206,982
Current tax liability 16 5,135 7,667
Current liabilities   290,472 265,499
 
Total liabilities   432,964 377,360
 
Total equity and liabilities   873,717 787,291

The notes 1 to 52 are an integral part of these consolidated financial statements.